The impact of intermittent fasting on fertility: A focus on polycystic ovary syndrome and reproductive outcomes in Women — A systematic review

Summary

This 2025 systematic review specifically addresses how intermittent fasting affects fertility and reproductive hormones in women with polycystic ovary syndrome (PCOS) — the most common endocrine disorder of reproductive-aged women, characterized by hyperandrogenism, insulin resistance, and menstrual irregularity. The authors synthesized three included studies of time-restricted feeding (TRF) and related IF protocols in PCOS patients. The findings were notably favorable. Menstrual regularity improved in 33–40 percent of participants — meaning a third or more of women with previously irregular cycles reported normalized cycling after TRF intervention. Hormonal changes pointed in the right direction for the PCOS phenotype: total testosterone fell about 9 percent, free androgen index dropped 26 percent, sex hormone-binding globulin rose, and anti-Müllerian hormone and luteinizing hormone both decreased. The review concludes that intermittent fasting, particularly time-restricted feeding, shows potential as a non-pharmacological adjunct intervention for improving reproductive health and fertility in women with PCOS by addressing the core pathophysiological mechanisms (insulin resistance, hyperandrogenism) that drive the syndrome.